medisourceasia.com logo

Market

Trendz  & Analysis


Home

About 
medisourceasia

Magazine
Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info

Contact

 

Indian Lab Chemicals, Equipment Market Clocks 40% Growth

 


Indian laboratory chemical and equipment market in the country is on an over drive. While the lab chemicals market in the country is estimated to be around Rs 200 crore and growing at 30 per cent annually, the lab equipment sector is generating a turnover of $750 million with 10 per cent growth. Both sectors put together are registering 40 per cent annual growth rates.

The main reason for the buoyancy in the lab chemical market is the fact that Indian companies have been stepping up their R&D activity in pharmaceuticals and biotech drug development. Indian companies are making inroads into global markets, and a strong Intellectual Property Regime (IPR) pipeline will give them an edge, stated VR Kannan, pharma consultant.

Companies are also strictly adhering to global norms and guidelines of good laboratory practices to survive in a highly competent scenario, added Kannan.

In the lab chemicals space, Jubilant Organosys is one of the largest speciality chemicals companies in the country. Other players are Ranbaxy (New Delhi) SD Fine Chemicals (Mumbai), NICE (Kochi), Leonid (Bangalore and Loba (Mumbai).

The market for lab equipment is dominated by multinational companies, like Waters, Millipore, Sartorious Applera Corp, Thermo Electron, Agilent Technologies, Perkin Elmer, Shimadzu, GE Healthcare, Bruker Group, Beckman Coulter and Varian.

In the area of lab chemicals, there is cut throat competition in India for quality and pricing with the presence of Chinese products, pointed out S Paul Joshua, manager, quality control, Leonid Chemicals. In this regard companies are gearing up for massive facility expansion to beat Chinese competition.

From Sigma Aldrich to Jubilant, Waters, Sartorius have made facility expansion to gear up for the Indian market needs largely driven by contract research orders, stated Shyam S Bhartia, chairman and managing director, Jubilant Organosys.

Lab equipment players have also seen major expansion and growth. With Indian pharma-biotech companies showing an increased awareness for the need for good quality lab infrastructure, it is boom time for the business," stated Amit Chatterjee, MD, Sartorius India.

For Waters India, the increased awareness on GLP is viewed as a great time to come up with products having superior technology and competitive pricing, stated KV Venugoplan, president, Waters India.

For the lab equipment majors, 43 per cent of the business is generated from the research and development institutes. This is followed by analytical services 24 per cent, quality assurance and quality controls 20 per cent. In India with the patent regime, there has a profile growth of the research and development activities.

(Ref: Chronicle Pharmabiz dated August 2, 2007)

Advertisement

 

Archives

More...

Next

Back To Top | Back